Veeramani Preethish-Kumar

Veeramani Preethish-Kumar

Auto-generated profile, based on publicly available information

Veeramani Preethish-Kumar

Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2019 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
JOJulien Oury
Julien Oury
YLYun Liu
Yun Liu
ATAna Töpf
Ana Töpf
STSlobodanka Todorovic
Slobodanka Todorovic
EHEsthelle Hoedt
Esthelle Hoedt
SBSteven Burden
Steven Burden
Complex mechanisms are required to form neuromuscular synapses, direct their subsequent maturation, and maintain the synapse throughout life. Transcriptional and post-translational pathways play important roles in synaptic differentiation and direct the accumulation of the neurotransmitter receptors, acetylcholine receptors (AChRs), to the postsynaptic membrane, ensuring for reliable synaptic transmission. Rapsyn, an intracellular peripheral membrane protein that binds AChRs, is essential for synaptic differentiation, but how Rapsyn acts is poorly understood. We screened for proteins that coisolate with AChRs in a Rapsyn-dependent manner and show that microtubule actin cross linking factor 1 (MACF1), a scaffolding protein with binding sites for microtubules (MT) and actin, is concentrated at neuromuscular synapses, where it binds Rapsyn and serves as a synaptic organizer for MT-associated proteins, EB1 and MAP1b, and the actin-associated protein, Vinculin. MACF1 plays an important role in maintaining synaptic differentiation and efficient synaptic transmission in mice, and variants in MACF1 are associated with congenital myasthenia in humans.

1 November 2016 in Neuromuscular Disorders
Verified
Journal Article
Closed access
KPKiran Polavarapu
Kiran Polavarapu
MMMahadevappa Manjunath
Mahadevappa Manjunath
VPVeeramani Preethish-Kumar
Veeramani Preethish-Kumar
DSDeepha Sekar
Deepha Sekar
SVSeena Vengalil
Seena Vengalil
ANAtchayaram Nalini
Atchayaram Nalini

1 March 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
NMNiranjan Prakash Mahajan
Niranjan Prakash Mahajan
MLMallika Lavania
Mallika Lavania
ISItu Singh
Itu Singh
SNSaraswati Nashi
Saraswati Nashi
VPVeeramani Preethish-Kumar
Veeramani Preethish-Kumar
ANAtchayaram Nalini
Atchayaram Nalini
Resistance to anti-leprosy drugs is on the rise. Several studies have documented resistance to rifampicin, dapsone, and ofloxacin in patients with leprosy. We looked for point mutations within the folP1, rpoB, and gyrA gene regions of the Mycobacterium leprae genome predominantly in the neural form of leprosy. DNA samples from 77 nerve tissue samples were polymerase chain reaction (PCR)-amplified for M leprae DNA and sequenced for drug resistance–determining regions of genes rpoB, folP1, and gyrA. The mean age at presentation and onset was 38.2 ± 13.4 (range 14–71) years and 34.9 ± 12.6 years (range 10–63) years, respectively. The majority had borderline tuberculoid leprosy (53 [68.8%]). Mutations associated with resistance were identified in 6/77 (7.8%) specimens. Mutations seen were those associated with resistance to rifampicin, ofloxacin, and dapsone. All the six patients were drug-naive. The clinical and pathological manifestations in this group did not differ from the drug-sensitive group. This study highlights the occurrence of resistance to the standard multidrug therapy and ofloxacin in leprosy. Among the entire cohort, 1/77 (1.3%) showed resistance to rifampicin, 2/77 (2.6%) to dapsone, and 5/77 (6.4%) to ofloxacin. Six new patients showing infection by mutant strains indicated the emergence of primary resistance. Resistance to ofloxacin could be due to frequent use of quinolones for many bacterial infections. The results of the study indicate the need for development of a robust and strict surveillance system for detecting drug resistance in leprosy in India.

30 August 2016 in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Verified
Journal Article
Closed access
RSRavinder-Jeet Singh
Ravinder-Jeet Singh
VPVeeramani Preethish-Kumar
Veeramani Preethish-Kumar
KPKiran Polavarapu
Kiran Polavarapu
SVSeena Vengalil
Seena Vengalil
CPChandrajit Prasad
Chandrajit Prasad
ANAtchayaram Nalini
Atchayaram Nalini
Preferential involvement of C7, C8, T1 level anterior horn cells is a typical feature in Hirayama disease/brachial monomelic amyotrophy (BMMA). There are no clinico-electrophysiological studies to substantiate the peculiar pattern of muscle involvement. Thirty subjects, 10 in each group of BMMA, amyotrophic lateral sclerosis (ALS) and age-matched normal healthy subjects underwent detailed clinical and electrophysiological testing. Results showed that the mean age at evaluation for BMMA and ALS patients was 25.8 ± 3.8 and 51.8 ± 9.5 years, respectively; illness duration was 8.1 ± 5.7 years and 11.14 ± 2.85 months, respectively. Clinically, all BMMA patients had reverse of split hand (RSH) syndrome [abductor digiti minimi (ADM) affected more than abductor pollicis brevis (APB)], while 7/10 ALS patients had classical split hand syndrome (APB affected more than ADM). In BMMA, the compound muscle action potential (CMAP) of APB was preserved but reduced/absent in ADM compared to the ALS group which demonstrated reverse findings. APB/ADM ratio was >0.8 in the BMMA group (>1.4 in 80%), around 1.0 in normal controls (none had >1.4) and <0.8 in ALS (70% having values <0.6). In conclusion, RSH syndrome may provide valuable diagnostic clues to differentiate this relatively self-restricted disease from progressive degenerative disease like ALS.

24 July 2018 in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Verified
Journal Article
Closed access
PTPriya Treesa Thomas
Priya Treesa Thomas
MWManjusha G. Warrier
Manjusha G. Warrier
ASArun Sadasivan
Arun Sadasivan
BBBhuvaneshwari Balasubramanium
Bhuvaneshwari Balasubramanium
VPVeeramani Preethish-Kumar
Veeramani Preethish-Kumar
ANAtchayaram Nalini
Atchayaram Nalini
Aim: Amyotrophic lateral sclerosis (ALS) or motor neuron disease (MND) is a progressive degenerative disorder that can have significant debilitating impact. Few studies have explored living with ALS in the developing countries. The study aims to understand the relationship between functionality, quality of life, and caregiver burden in ALS in the sociocultural scenario in India. Methods: A cross-sectional descriptive study was performed among 30 persons with ALS and their caregivers (men = 19; women = 11) receiving treatment from a national quaternary referral care center for Neurological disorders in Southern India. All patients were diagnosed as Definite ALS according to El Escorial Criteria. The mean age at onset of illness was 51.6 years and mean duration of illness at presenting to hospital was 11 months. The caregivers were spouses, offspring, or siblings. Variables were assessed with ALS Functional Rating Scale Revised (ALSFRS- R), ALS Specific Quality of Life Scale (ALSSQOL-R) with the patients and Zarit Burden Interview (ZBI) with the caregiver. Results: Functionality and quality of life negatively correlated with caregiver burden. Caregiver burden was negatively associated with “negative emotional state” and “interaction of the patient with family and environment”, sub domains in ALSQOL scale. No significant association was noted between caregiver burden and intimacy, religiosity as well as physical symptoms domains of quality of life. Conclusion: ALS patients and caregivers would benefit from structured care plan that is sensitive to the impact of the illness on the specific domains of quality of life as well as the deterioration in the neurological functioning.

10 November 2016 in Journal of Human Genetics
Verified
Journal Article
Closed access
WZWenhua Zhu
Wenhua Zhu
SMSatomi Mitsuhashi
Satomi Mitsuhashi
TYTakahiro Yonekawa
Takahiro Yonekawa
SNSatoru Noguchi
Satoru Noguchi
JHJosiah Chai Yui Huei
Josiah Chai Yui Huei
INIchizo Nishino
Ichizo Nishino